Atlantic Union Bankshares’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.76M Sell
160,996
-84,692
-34% -$4.94M 0.19% 118
2025
Q4
$13.3M Sell
245,688
-3,230
-1% -$155K 0.25% 87
2025
Q3
$11.2M Buy
248,918
+8,955
+4% +$418K 0.21% 103
2025
Q2
$11.1M Buy
239,963
+92,172
+62% +$4.52M 0.25% 92
2025
Q1
$9.01M Buy
147,791
+117,697
+391% +$6.86M 0.55% 48
2024
Q4
$1.7M Sell
30,094
-1,916
-6% -$107K 0.1% 157
2024
Q3
$1.66M Sell
32,010
-280
-0.9% -$13.1K 0.1% 165
2024
Q2
$1.34M Sell
32,290
-2,210
-6% -$98.9K 0.08% 174
2024
Q1
$1.87M Sell
34,500
-650
-2% -$33.1K 0.16% 131
2023
Q4
$1.8M Sell
35,150
-4,006
-10% -$210K 0.17% 127
2023
Q3
$2.27M Sell
39,156
-1,111
-3% -$68.1K 0.23% 95
2023
Q2
$2.58M Sell
40,267
-5,438
-12% -$365K 0.26% 89
2023
Q1
$3.17M Buy
45,705
+646
+1% +$45.6K 0.33% 81
2022
Q4
$3.24M Sell
45,059
-2,025
-4% -$153K 0.35% 76
2022
Q3
$3.35M Sell
47,084
-1,649
-3% -$120K 0.38% 74
2022
Q2
$3.75M Sell
48,733
-326
-0.7% -$24.8K 0.38% 75
2022
Q1
$3.58M Sell
49,059
-895
-2% -$60.1K 0.31% 84
2021
Q4
$3.11M Sell
49,954
-4,597
-8% -$270K 0.26% 90
2021
Q3
$3.23M Sell
54,551
-1,264
-2% -$83.2K 0.3% 83
2021
Q2
$3.73M Buy
55,815
+1,090
+2% +$71.1K 0.36% 75
2021
Q1
$3.46M Sell
54,725
-4,359
-7% -$271K 0.35% 73
2020
Q4
$3.67M Sell
59,084
-1,746
-3% -$107K 0.38% 70
2020
Q3
$3.67M Sell
60,830
-539
-0.9% -$32.4K 0.43% 63
2020
Q2
$3.61M Sell
61,369
-350
-0.6% -$20.9K 0.45% 62
2020
Q1
$3.44M Buy
61,719
+520
+0.8% +$31.8K 0.5% 54
2019
Q4
$3.93M Buy
61,199
+1,936
+3% +$111K 0.5% 60
2019
Q3
$3M Sell
59,263
-220
-0.4% -$10.3K 0.4% 73
2019
Q2
$2.7M Buy
+59,483
New +$2.77M 0.36% 80
2018
Q4
Sell
-3,743
Closed -$232K 128
2018
Q3
$232K Buy
3,743
+68
+2% +$4.04K 0.07% 118
2018
Q2
$204K Hold
3,675
0.07% 121
2018
Q1
$232K Sell
3,675
-150
-4% -$9.65K 0.07% 120
2017
Q4
$235K Sell
3,825
-300
-7% -$18.8K 0.07% 123
2017
Q3
$263K Sell
4,125
-114
-3% -$6.66K 0.09% 121
2017
Q2
$236 Sell
4,239
-166
-4% -$9.03K 0.08% 124
2017
Q1
$240 Buy
4,405
+480
+12% +$26.3K 0.09% 121
2016
Q4
$229K Hold
3,925
0.09% 122
2016
Q3
$212K Sell
3,925
-600
-13% -$38.5K 0.08% 129
2016
Q2
$333K Buy
4,525
+350
+8% +$24.7K 0.13% 109
2016
Q1
$267K Sell
4,175
-100
-2% -$6.31K 0.11% 117
2015
Q4
$295K Sell
4,275
-954
-18% -$63K 0.13% 114
2015
Q3
$309K Buy
5,229
+466
+10% +$29.6K 0.14% 110
2015
Q2
$317K Sell
4,763
-3,885
-45% -$256K 0.15% 101
2015
Q1
$558K Sell
8,648
-134
-2% -$8.39K 0.26% 87
2014
Q4
$518K Buy
8,782
+400
+5% +$22.6K 0.23% 89
2014
Q3
$429K Sell
8,382
-16
-0.2% -$799 0.2% 98
2014
Q2
$407K Buy
8,398
+201
+2% +$9.9K 0.19% 99
2014
Q1
$404K Buy
+8,197
New +$436K 0.19% 99

Other funds holding BMY

Atlantic Union Bankshares's BMY Position: Q1 2026 in Review

Atlantic Union Bankshares reduced its Bristol-Myers Squibb (BMY) stake by 34% in Q1 2026, selling an estimated $4.94M and leaving 160,996 shares worth $9.76M. The position accounts for 0.19% of the portfolio, ranked #118.

Atlantic Union Bankshares first reported a position in BMY in Q1 2014 and has held it in 47 quarters since. The position peaked at $13.3M in Q4 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Atlantic Union Bankshares held 160,996 shares of Bristol-Myers Squibb worth $9.76M as of Q1 2026.
  • Atlantic Union Bankshares sold 84,692 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.94M.
  • Bristol-Myers Squibb made up 0.19% of Atlantic Union Bankshares's portfolio in Q1 2026, its #118 holding.
  • Atlantic Union Bankshares first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 47 quarters since.
  • Atlantic Union Bankshares's Bristol-Myers Squibb position peaked at $13.3M in Q4 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.